Microbiome linked to response to new cancer drugs

Preliminary work in mouse models showed that the composition of the gut microbiome could predict the response of animals to a new type of anti-cancer drug, immune checkpoint inhibitors. Recently, this work was validated in patients with cancer.

For a summary of the work, including links to the scientific articles, click here